Advertisement
Organisation › Details
Fountain Healthcare Partners Fund III, L.P.
Fountain Healthcare Partners is a life science venture capital fund with offices in Dublin, and New York. Founded in 2008, Fountain is Ireland’s largest dedicated life science venture capital fund with more than €300 million under management. Fountain invests in entrepreneurs and companies with disruptive technologies or products that have a clear pharmacoeconomic benefit and a defined pathway to commercialisation, value enhancement and exit. Fountain typically leads or co-leads its investments and has sourced private and public deals from start-ups, corporate spin-outs and turnaround situations. The three principals at Fountain Healthcare Partners Fund III, Manus Rogan, Aidan King and Ena Prosser brings to investees over 70 years of collective experience in the pharmaceutical industry, corporate venture capital and VC across multiple investment and market cycles. *
Start | 2019-05-23 closing, first | |
Group | Fountain Healthcare Partners (IE) | |
Industry | Fountain Healthcare Partners Fund III, L.P. | |
Industry 2 | LIFE SCIENCES | |
Person | Rogan, Manus (Fountain Healthcare Partners 201811 Managing Partner + Co-Founder) | |
Person 2 | King, Aidan (Fountain Healthcare Partners 202010 Managing Partner + Co-Founder) | |
Region | Dublin | |
Country | Ireland, Republic of | |
City | n. a. Dublin | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
Currency | EUR | |
Annual sales | 125,000,000 (fund size at closing (2020) 2020-11-02) | |
* Document for »About Section«: Fountain Healthcare Partners. (11/2/20). "Press Release: Fountain Healthcare Partners Announces Final Close of €125 Million for Fund III". | ||
Record changed: 2021-04-05 |
Advertisement
More documents for Fountain Healthcare Partners (IE)
- [1] [iito] Business Intelligence. (11/8/20). "The [LSUS] Newsletter Is Out! Hand-picked & Manually Edited Transatlantic Life Science Business News from Europe and North America". Bremen....
- [2] Fountain Healthcare Partners. (11/2/20). "Press Release: Fountain Healthcare Partners Announces Final Close of €125 Million for Fund III"....
- [3] Priothera Ltd.. (10/12/20). "Press Release: Priothera Closes €30 Million Series A Financing to Develop Highly Promising Therapies for Acute Myeloid Leukemia (AML)". Dublin....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top